Financial Support
Providing financial resources and funding to organizations working to combat adult sickle cell disease in Malawi.
Patient Care
Supporting locally-based physicians, clinics, and organizations providing ongoing care to adults with sickle cell disease.
Clinical Research
Advancing local research and studies to more fully understand the range of SCD complications in Malawian adults and Sub-Saharana Africa.
15,000,000
Estimated number of people living with sickle cell disease in the region.
1-13%
Percent of adults with sickle cell anemia in Malawi who regularly take hydroxyurea.
$320
The cost to treat a single patient with SCD at a local clinic for a full year.
$64,000
The cost to fund both the clinic and research teams for a full year.
LEARN MORE ABOUT THE MALAWI SICKLE CELL INITIATIVE
OUR MISSION
Come along side our mission to support all the work and research actively underway.
OUR STORY
Learn about how the MSCI came to be and our long term vision for ongoing support.
OUR TEAM
Meet the dedicated local doctors, researchers, and clinical care workers at the heart of the initiative.
“I have been to many hospitals in Malawi, but I think the care here is the best. Sometimes you go to places and the doctors don’t know what to do, but here they know what questions to ask, which tests to order, and what medications to give.”
– Jane, Sickle Cell Warrior
DONATE TO THE INITIATIVE
At MSCI, we know that local communities and doctors have the strength and vision to thrive. We are simply helping facilitate our opportunity to support them.
You donation goes a long way towards creating lasting patient care, supporting ongoing research efforts, and helping improve the quality of life for all adults affected by SCD in Malawi.
Funds 100 doses of Hydroxyurea, a critical drug for the treatment of SCD, which prompts the body to produce fetal hemoglobin. This prevents red blood cells from turning into a stiff, sickle shape.
